According to a study, a new breast cancer drug that lowers oestrogen levels is far more effective than the most popular current therapy. US researchers compared letrozole with tamoxifen, using each on its own, reported the Daily Express. They found post-menopausal women on letrozole were 20 per cent less likely to suffer a return of breast cancer over an eight-year period and 21 per cent less likely to die.
more recommended stories
Study finds all Myanmar mouth cancer patients chew betel quid
A study in Myanmar has found.
Man’s best friend can detect prostate cancer: Study
A new study suggests that trained.
Old drug effective against drug-resistant leukaemia
An existing anti-cancer drug has been.
Two new genetic variants to breast cancer found
In a worldwide study of the.
FDA approves Pfizer’s breast cancer drug
The U.S. Food and Drug Administration.
Young Asians at greater skin cancer risk in Australia
Researchers from University of Adelaide shows.